Winter 2023: Antineoplastic Therapy and Immunotherapy Course

February 6, 2023 to March 14, 2023

This four-day course is designed to address the needs of the nursing and other oncology professionals in relation to antineoplastic agents  and immunotherapies.  It includes information on current and investigational pharmacotherapy, safe handling, administration of antineoplastic agents, and various issues concerning the management of patients receiving cancer therapy.  Learners must attend all four days of class and  pass an exam with 80% accuracy at the end of the course in order to claim credit for the course .

This course is NOT a certification course and is not intended to measure competency.  Individual institutions are responsible for determining their own requirements for assessing clinical competency.

It is strongly recommended that attendees have taken the Foundations to Practice series prior to completing this course.

All courses are sponsored by UPMC Hillman Cancer Center.

The faculty consists of healthcare professionals with expertise in cancer care at UPMC.

Target Audience

RN

PA

Learning Objectives

After participation in this activity, the learner will be able to:

Discuss the expectations related to class content and the participant’s professional responsibilities

Discuss the roles of antineoplastic therapy and immunotherapy in the treatment of cancer

Recall the pharmacology of different classes of antineoplastic and supportive therapies

Recognize side effects and organ toxicities that patients may experience while receiving antineoplastic and supportive therapies

Discuss management strategies for patients receiving antineoplastic and supportive therapies, including the prevention and treatment of toxicities and side effects

Describe the safe administration of antineoplastic and supportive therapies

Identify interventions to prevent chemotherapy errors

Develop a patient care management plan for a patient receiving antineoplastic therapies and supportive therapies

Identify three resources for oncology healthcare providers to utilize

Demonstrate that learning has occurred by achieving at least an 80% on the final exam

 

 

Course summary
Available credit: 
  • 25.50 AAPA Category I CME
  • 25.50 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 0.00 Attendance
Course opens: 
01/23/2023
Course expires: 
03/31/2023
Event starts: 
02/06/2023 - 6:00am EST
Event ends: 
03/14/2023 - 6:00pm EDT

Day 1: Monday, October 10, 2022

8:00 am

Course Overview

Lynne O’Connor, MSN, RN

8:15 am

Antitumor Antibiotics

Brian Miller, PharmD

9:30 am

Cytokines, L Asparaginase, and Vaccine Therapy

Tim George, PharmD, BCOP

10:25 am

Break

 

10:35 am

Antimetabolites

Tim George, PharmD, BCOP

11:45 am

Growth Factors

Jaime Kriner, PA-C

12:30 pm

Lunch

 

1:10 pm

Organ Toxicities

Linda Pfeifer, CRNP

2:20 pm

Hormone Therapy: Breast Cancer

Courtney Stetor, MPAS PA-C

2:40 pm

Break

 

2:50 pm

Hormone Therapy: Prostate

Tom Boyer PA-C

3:20pm

Error Prevention

Amy DiMaggio, MSN, RN, CMSRN, OCN

3:50 pm AdjournmentLynne O'Connor MSN , RN 

 

Day 2: Monday, October 17, 2022

8:00 am

Welcome

Lynne O’Connor, MSN, RN

8:05 am

Principles of Antineoplastic Drug Therapy

Ernie Sanchez, PharmD

9:00 am

Administration

Markie Rearick, MSN, RN, BMTCN

10:15 am

Break

 

10:25 am

Monoclonal Antibodies: Part 1

Melissa Bastacky, PharmD, BCOP

11:30 am

Monoclonal Antibodies: Part 2

Melissa Bastacky, PharmD, BCOP

12:25 pm

Lunch

 

1:05 pm

CAR-T Therapy

Shrina Duggal, PharmD, BCOP

2:00 pm

Alkylating Agents

Trish Seaman, BSN, RN, CMSRN

3:25 pm

Break

 

3:35 pm

Extravasations

Katey Murgi, MSN, RN

4:15 pm

Adjournment

Lynne O’Connor   MSN, RN

Day 3: Monday, October 24, 2022

8:00 am

Welcome

Lynne O’Connor, MSN, RN

8:05 am

Tyrosine Kinase Inhibitors: Part One

Amanda Agnew, PharmD, BCOP

8:50 am

Tyrosine Kinase Inhibitors: Part Two

Jason Steele, PharmD, BCOP

9:45 am

Protectants

Lynne O’Connor, MSN, RN

10:15 am

Break

 

10:25 am

Miscellaneous Agents                                            

Tim Brenner, PharmD, BCOP

12:25 pm

Lunch

 

1:05 pm

Genetics vs. Genomics

Melissa K. Bourdius, MS, CGC

1:50 pm

Hypersensitivity

Alyssa Owens, MPAS, PA-C

2:40 pm

Break

 

2:50 pm

Oral Adherence

Hannah Peterson  PA-C

3:30 pm

Adjournment

Lynne O’Connor, MSN, RN

 

 

 

Day 4: Thursday, October 31, 2022

8:00 am

Welcome

Lynne O’Connor, MSN, RN

8:05 am

Plant Alkaloids

Nicole Kahler, DNP, CRNP, AOCNP

9:20 am

Homework Review

Lynne O’Connor, MSN, RN

9:50 am

Break

 

10:00 am

Case Study

Brittni Prosdocimo, MSN, RN, BMTCN

10:30 am

Review/Jeopardy

Amy DiMaggio, MSN, RN, CMSRN, OCN

Lynne O’Connor, MSN, RN

Brittni Prosdocimo, MSN. RN, BMTCN

12:00 pm

End of Class/Adjournment

Lynne O’Connor, MSN, RN

 

UPMC Hillman Cancer Center
Pittsburgh, PA 15232
United States

 

 

Amanda Agnew, PharmD, BCPS,

BCOP

Clinical Oncology Pharmacist

UPMC Hillman Cancer Center

Melissa Bastacky, PharmD, BCOP

Clinical Pharmacy Specialist

UPMC Hillman Cancer Center

Melissa K. Bourdius, MS, CGC

Genetics Counselor

Special Genetic Counsel

UPMC Magee-Womens Hospital

 

Tom G. Boyer, PA-C

Physician Assistant

University of Pittsburgh Physicians

Tim Brenner, PharmD, BCOP

Clinical Pharmacy Specialist

UPMC Hillman Cancer Center

Amy DiMaggio, MSN, RN, CMSRN, OCN

Clinical Education Specialist

UPMC Hillman Cancer Center

Shrina Duggal, PharmD, BCOP

Lead Clinical Oncology Pharmacist

UPMC Hillman Cancer Center

Timothy George, PharmD, BCOP

Clinical Pharmacy Specialist

UPMC Hillman Cancer Center

Nicole Kahler, DNP, CRNP, AOCNP

Nurse Practitioner

University of Pittsburgh Physicians

Jaime Kriner, PA-C

Director, APP Relations

UPMC Hillman Cancer Center

Brian Miller, PharmD

Manager, Investigational Drug Services Pharmacy

UPMC Hillman Cancer Center

Katey Murgi, MSN, RN

Clinical Education Specialist

UPMC Hillman Cancer Center

Lynne O’Connor, MSN, RN

Clinical Education Specialist

UPMC Hillman Cancer Center

Alyssa Owens, MPAS, PA-C                                               

Physician Assistant

UPMC Hillman Cancer Center

Hannah Peterson, PA-C

Physician Assistant

UPMC Hillman Cancer Center

Linda Pfeifer, CRNP, Expert                     
Nurse Practitioner

UPMC Hillman Cancer Center

Brittni Prosdocimo, MSN, RN, BMTCN

Advanced Clinical Education Specialist

UPMC Hillman Cancer Center

Markie Rearick, MSN, RN, BMTCN

Clinical Education Specialist

UPMC Shadyside

Ernest M. Sanchez, Pharm.D.

Lead Pharmacist of Oncology Operations, Department of Pharmacy

University of Pittsburgh Medical Center

Shadyside Hospital

Trish Seaman, MSN, RN, CMSRN

Nurse Educator

UPMC Hillman Cancer Center

Central Region

Jason Steele, PharmD, BCOP

Oncology Clinical Pharmacist

UPMC Hillman Cancer Center

Courtney Stetor, MPAS PA-C

Physician Assistant

UPMC Hillman Cancer Center

Upper St Clair

 

 

 

Disclosure of Conflicts of Interest

All individuals in a position to control the content of this education activity are required to disclose all relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.

The following information was provided: Amanda Agnew, Melissa Bastacky, Melissa K. Bourdius, Thomas G. Boyer, Timothy Brenner, Amy DiMaggio, Shrina Duggal, Timothy George, Nicole Kahler, Jaime Kriner, Brian Miller, Katey Murgi, Lynne O’Connor, Alyssa Owens, Hannah Peterson, Linda Pfeifer, Markie Rearick, Brittni Prosdocimo, Ernest Sanchez, Trish Seaman, Jason Steele, Courtney Stetor, and the planning committee for this activity did not have any relevant financial relationships with a commercial interest.

 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The maximum number of hours awarded for this Continuing Nursing Education activity is 25.5 contact hours.

The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 25.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

 

 

Available Credit

  • 25.50 AAPA Category I CME
  • 25.50 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 0.00 Attendance
Please login or register to take this course.